DCF — RAPIDES REGIONAL MEDICAL CENTER
Enterprise Value: $-613.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-613.0M
Enterprise Value
$-189.0M
PV of Cash Flows
$-424.0M
PV of Terminal Value
$-682.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $237.3M | $-40.9M | -17.0% | $-50.9M | $-46.3M |
| Year 2 | $244.4M | $-39.7M | -16.0% | $-50.0M | $-41.3M |
| Year 3 | $251.8M | $-38.3M | -15.0% | $-49.0M | $-36.8M |
| Year 4 | $259.3M | $-38.2M | -15.0% | $-49.2M | $-33.6M |
| Year 5 | $267.1M | $-38.7M | -14.0% | $-50.0M | $-31.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-613.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$230.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1772249632149568
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5